Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Hemorrhagic Stroke l: Introduction

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...

Hemorrhagic Stroke ll: Pathophysiology

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Glandular Fever.

Postgraduate medical journal·2011

Same author

A CASE OF TETANUS TREATED WITH INTRASPINAL INJECTIONS OF MAGNESIUM SULPHATE.

British medical journal·2010

Same author

GLANDULAR FEVER.

British medical journal·2010

Same author

Remarks on THE HAEMORRHAGIC DIATHESIS.

British medical journal·2010

Same author

Observations on the DIAGNOSIS AND TREATMENT OF CATARRHAL AND ULCERATIVE COLITIS.

British medical journal·2010

Same author

An Address on SYMPTOMS AND PATHOGENESIS OF THE HAEMORRHAGIC DIATHESIS.

British medical journal·2010

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring

Published on: May 21, 2017

The Hæmorrhagic Diathesis.

Proceedings of the Royal Society of Medicine

|December 9, 2009

Summary

This summary is machine-generated.

Purpura is a clinical entity primarily caused by capillary defects, not platelet variations. Understanding capillary permeability is key to diagnosing and treating purpura and related conditions like urticaria.

More Related Videos

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Published on: August 30, 2020

Related Experiment Videos

Last Updated: Jun 18, 2026

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring

Published on: May 21, 2017

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Published on: August 30, 2020

Area of Science:

Hematology
Dermatology
Vascular Biology

Background:

Primary purpuras represent a unified clinical condition.
Platelet count fluctuations do not inherently cause hemorrhages.
Capillary integrity is crucial in purpura pathogenesis.

Purpose of the Study:

To elucidate the primary cause of hemorrhagic states in purpura.
To differentiate the roles of platelets and capillaries in purpura.
To establish the relationship between purpura, urticaria, and Henoch-Schönlein purpura.

Main Methods:

Clinical observation and analysis of purpura cases.
Histopathological examination of capillary endothelium.
Comparative study of platelet counts and bleeding tendencies.
Review of related dermatological conditions.

Main Results:

Hemorrhagic states in purpura are fundamentally linked to capillary endothelium defects or increased permeability.
Platelet variations are secondary to capillary conditions and not the direct cause of bleeding.
The Henoch-Schönlein type of purpura demonstrates an intermediate relationship with urticaria.

Conclusions:

The essential cause of purpura's hemorrhagic state is capillary endothelial dysfunction.
Platelet counts are not the primary determinant of bleeding in purpura.
Purpura shares etiological links with urticaria, with Henoch-Schönlein purpura as a connecting condition.